Blood Cancer Therapeutics: Global Markets to 2023 - Highly Sensitive...

01/08/19

Blood Cancer Therapeutics: Global Markets to 2023 - Highly Sensitive Tests to Detect Minimal Residual Disease - ResearchAndMarkets.com  Business Wire

DUBLIN--(BUSINESS WIRE)--The "Blood Cancer Therapeutics: Global Markets to 2023" report has been added to ResearchAndMarkets.com's offering.

[more]